Demand Strong, Execution Risk Ahead
Revenue surged 31.7% with adjusted EBITDA margins at 28.3%, but management warned Q3 moderation and flagged execution risks on simultaneous new facility ramps that could test the 50% FY28 growth target.
25.2%
Includes ₹7.82 Cr Ind AS 29 non-cash loss
28.3%
ex hyperinflation charge; +3.1pp vs guidance
47.2%
Up from 44.6% prior; procurement synergies
−17.1%
Q4 FY26 was elevated; YoY +31.7% is the run-rate
Where the margin really sits
The reported EBITDA margin of 25.2% includes a ₹7.82 crore non-cash charge from Ind AS 29 hyperinflation accounting on Turkish operations. Strip that out and adjusted EBITDA margin is 28.3%, well above the 20% guidance. The beat is real — but this number comes with a timing caveat.
Current raw material movements will flow through the standalone financials primarily during Q2 and Q3. We therefore expect some temporary moderation in standalone margins, particularly in Q3.
Aluminum prices spiked in Q1. Quality Power's coil business has a 4–5 month manufacturing cycle, meaning that raw material cost hit will land in Q3 financials. Mehru, with an 8-week cycle, has already digested it. Management is signaling Q3 EBITDA margin compression to the high teens or low 20s before recovery in Q4 and H2 as new facility utilization ramps. This is a timing lag, not structural — but it's real and material to model.
Management claims vs. what holds up
"Excellent numbers especially on margin front" — Reported 25.2% EBITDA, 47.2% gross margin, strong despite commodity volatility
"Strong demand across portfolio; Endoks inquiry levels ahead of expectations" — Order book ₹1,945 Cr (1.9x revenue), USD80M+ BESS pipeline confirmed
"Order book visibility on Q3 onwards for Sangli commercial production" — Trial Aug 2026, but 60 customer audits over 6 months is a real bottleneck; first orders Q4 at earliest
"No structural issues in Sangli, only minor last-mile delays" — Machinery ongoing, BCC pending, audit cycle is a constraint not a detail
"Margin guidance 20% or high teens remains intact" — Maintained, but Q3 moderation explicitly flagged; all new orders booked above guidance levels
What changed on this call
FY27 revenue growth
20% (₹1,229 Cr at +20%)
Maintained; no raise despite strong Q1 (cautious positioning)
15–20%
FY28 revenue growth
50% (maintained)
Maintained; contingent on Sangli/Endoks ramp execution
50%+
Mehru EBITDA margin
18% going forward
Upgrade; confident despite commodity volatility
~15% (vague)
Endoks EBITDA margin
~18% going forward (STATCOM/SVC at 25%, BESS TBD)
Upgrade; clarity pending first BESS shipments
Vague
Sangli timeline
Trial Aug 2026, 6-month audit cycle, Q3–Q4 first orders
Downgrade; delays acknowledged but framed as minor
Q2 commercial aspiration
Capex raise scope
<₹500 Cr (Winwin + ₹50 Cr facility capex + US + Europe R&D)
Widened ambition; timelines soft
Winwin (₹315 Cr) + US entry
The bull-bear ledger
31.7% YoY revenue growth in a commodity-volatile quarter shows genuine demand strength
Order book ₹1,945 Cr (1.9x revenue) gives 15-month visibility; capacity is the constraint, not demand
Quality Power standalone revenue ₹69 Cr, up 87% YoY — core business accelerating
Gross margin 47.2% (up from 44.6%) driven by pricing power and procurement synergies
Mehru and Endoks margins revised UP; management confidence in sustainability signaled
FII ownership up 1.08pp to 3.36% post-result; institutions buying into 13% drawdown
Reported EBITDA margin includes ₹7.82 Cr non-cash Ind AS 29 charge; headline masks dependency
Q3 margin moderation explicit: raw material lag + new facility fixed costs will compress margins
Sangli facility: BCC pending, trial Aug, 60 audits over 6 months — management downplays but this is a hard bottleneck
Simultaneous Sangli, Endoks, Winwin ramp creates management bandwidth risk and near-term ROIC drag
QoQ revenue −17.1% despite YoY +31.7% suggests Q4 FY26 was elevated; near-term sustainability unclear
Supply chain constraints (IGBT shortage, CTC cables, aluminum castings) could throttle volume despite demand
Stock down 13.3% from ATH; RSI 44 (neutral) — no capitulation yet, upside depends on execution
Ranked risks: what should concern a holder
1
HighExecution on simultaneous Sangli, Endoks, Winwin ramps
Sangli trial Aug, 6-month audit cycle, Endoks Q3 startup, Winwin Q4 consolidation all compete for management attention and capex. Any slippage defers ₹500+ Cr revenue to FY28, compressing FY27 EBITDA and proving caution in 20% guidance.
2
MediumQ3 EBITDA margin moderation material and real
Raw material lag + new facility fixed costs will compress standalone margins to high teens/low 20s. Recovery to 22%+ in Q4 would validate thesis. Staying below 20% would signal tighter execution than expected and reset FY28 confidence.
3
MediumSangli audit cycle bottleneck (60 audits, 6 months)
Single biggest determinant of Q3-Q4 revenue and order absorption. Management frames as 'minor sequencing'; reality is it's a hard constraint. Any rejection or delay defers volume and confidence significantly.
4
MediumSupply chain constraints (IGBT, CTC, castings, springs)
Global IGBT shortage; CTC cables, castings, springs all tight. Management says no single-point bottleneck, but if a critical component becomes unavailable, volume stalls despite order book. Procurement consolidation is mitigation, not guarantee.
5
LowEarnings quality: Ind AS 29 dependency
Non-cash charge of ₹7.82 Cr (3.1% of EBITDA) is manageable and non-recurring. Adjusted margin beat is cleaner but narrower. For FY27, it's a one-time; not systemic.
6
LowChinese competition in HVDC/GIS
TVA, Taikai, Pinggao allowed to bid, but most de-rated or idle. Local sourcing (60-70%) unchanged. Quality Power also supplies components to these OEMs, so indirect exposure, not direct threat.
How the street is positioned
Price and momentum: ₹1,249.3, down 13.3% from all-time high of ₹1,441, but above SMA50 (₹1,082) and SMA200 (₹893). RSI 44.3 (neutral). The stock retreated from euphoria but no capitulation signal.
Ownership flow: FII ownership up 1.08 percentage points to 3.36% in Q1 FY27, versus 2.28% in Q4. This is institutions adding post-result, seeing value in the drawdown. DII stable at 6.45%; promoter unchanged at 73.91%. No insider selling pressure near ATH.
Street read: The market is cautiously bullish but not euphoric. The 13% drawdown is correction not capitulation. FII buying into the dip is a contrarian signal that patient, execution-focused money is accumulating. Valuation is back to reasonable levels; risk-reward is balanced. Upside if audits pass and FY28 ramps; downside if execution slips. The stock is fairly valued here.
The debate
The honest read: Quality Power is a quality franchise with genuine demand tailwinds and a multi-factory transformation in progress. Q1 proved the model works at scale (31.7% growth, 28.3% adjusted EBITDA). The near term (Q3–Q4) is the test: Sangli audits, margin recovery timing, supply chains, management execution. If ramps succeed, the longer term (FY28) is attractive. The market is fairly priced at ₹1,249 for this risk. It's a hold waiting for Q3 audit progress and margin print to reset the narrative.
What to watch next
1 · Sangli customer audits (Sep–Oct 2026)
First Hitachi, Adani, Power Grid audits. Pass = Q4 order intake confidence. Delays or rejections = Q3-Q4 revenue miss and ramp reset. Single biggest determinant of FY27 guidance hold.
2 · Q3 FY27 EBITDA margin print (Nov 2026)
Will compression land at high teens or worse? This tests whether raw material lag and fixed costs match warning. Recovery to 22%+ in Q4 validates thesis; below 20% signals execution tighter than expected.
3 · Endoks PCS facility startup (Q3 2026)
Turkey power conversion systems facility online. Watch for supply delays (IGBTs), ramp hiccups, customer feedback. USD80M BESS pipeline needs this operational; Q3 delay pushes to Q4/FY28.
4 · Winwin acquisition close & integration (Q4 FY27)
₹315 Cr deal pending SEZ approvals. Watch for regulatory delays (common). Integration surprises (asset condition, customer attrition, overruns) could drag Q4 and reset FY28 assumptions.
The single number to track
Adjusted EBITDA margin (ex Ind AS 29). Q1 delivered 28.3%; guidance is 20%. The test: if Q3 dips to 18–20% as warned and recovers to 23–24% in Q4 and beyond, the execution story holds and FY28 50% growth is credible. If adjusted EBITDA margin stays below 20% through Q4, or if Q3 dips below 18%, management is struggling with fixed costs, utilization, or supply — and FY28 target is at risk. This single metric resolves whether transformation is on track or slipping.
Quality Power Q1 delivered a genuine win: 31.7% growth, strong margins, order visibility to support 50% FY28 target. The question is not demand — it's execution. Can three factories ramp without stumbling? Will audits pass, supply chains hold, and margins recover on schedule? The stock is fairly valued at ₹1,249 for this risk profile. It's a hold for the disciplined, a sell for the impatient, and a buy only when audits pass (Q4 2026) and margin recovery begins (H2 FY27). Watch Q3: that quarter resolves the execution case.
Informational and educational content only. Not investment advice.